Alemtuzumab biosimilar (Zhangjiang Biotechnology) | Interleukin Related interleukin-related.com

Product Name :
Alemtuzumab biosimilar (Zhangjiang Biotechnology)

Search keywords :
CD52

drugId :
null

Target Vo:
CAMPATH-1 antigen

Target Vo Short Name :
CD52

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Zhangjiang Biotechnology Co Ltd

Active Company_Name :
Shanghai Zhangjiang Biotechnology Co Ltd

Active Indication_Name:
Leukemia, Lymphocytic, Chronic, B-Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Met (C-Met) Antibody
Anti-Aurora A Antibody
Survivin Antibody (YA045): Survivin Antibody (YA045) is a non-conjugated and Rabbit origined monoclonal antibody about 16 kDa, targeting to Survivin. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts